ended5월 18일· 1 sources

퀀타매트릭스, '디라스트' 인도 진입…키트 '반복매출' 전환

Why it matters

QuantaMatrix's India market entry represents a crucial test of its business model transformation from equipment sales to recurring consumable revenue, necessary to achieve profitability amid significant operating losses. Success hinges on converting installed DiRAST devices into sustained hospital usage, generating the kit sales that drive IVD profitability. This Asian expansion validates whether the company can scale its recurring revenue model beyond Europe, a prerequisite for financial recovery.

1
Sources
+0
24h
Growth
126d
Active
DiRASTRecurring revenueIndia expansionAST kitSepsis diagnostics

Sources

Related Issues